Stockhub

Tricida, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

21 September 2022

  • curprev 07:4007:40, 21 September 2022 95.149.241.133 talk 535 bytes +535 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California..."
Retrieved from "https://stockhub.co/research/Tricida,_Inc."